PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32308543-4	2020	VEGF165 also promoted tyrosine phosphorylation of VEGFR-1 and VEGFR-2 in HUVECs, which was again abolished by TA.	Tranexamic Acid	110-112	fms related receptor tyrosine kinase 1	Homo sapiens	50-57	
32308543-5	2020	TA further showed similar effects to neutralization of VEGFR-1 and VEGFR-2 in inhibiting cell proliferation, migration, invasion and tube formation of HUVECs induced by VEGF165, suggesting that TA could inhibit angiogenesis by targeting VEGFRs in HUVECs.	Tranexamic Acid	194-196	fms related receptor tyrosine kinase 1	Homo sapiens	55-62	
32308543-6	2020	In addition, VEGF165 enhanced the expression of VEGFRs and promoted tyrosine phosphorylation of VEGFR-1 and VEGFR-2 in normal human melanocytes, which were also attenuated by TA.	Tranexamic Acid	175-177	fms related receptor tyrosine kinase 1	Homo sapiens	96-103	
32308543-7	2020	Furthermore, TA showed similar effects to neutralization of VEGFR-1 and VEGFR-2 in inhibiting tyrosinase activity, melanin production and even melanogenic proteins induced by VEGF165, suggesting that TA could reduce melanogenesis via inhibiting activation of VEGFRs and subsequent expression of melanogenic proteins in melanocytes.	Tranexamic Acid	200-202	fms related receptor tyrosine kinase 1	Homo sapiens	60-67